Tango Therapeutics Inc. (TNGX) PT Raised to $28 at Leerink Partners

April 13, 2026 4:09 PM

Leerink Partners analyst Andrew Berens raised the price target on Tango Therapeutics Inc. (NASDAQ: TNGX) to $28.00 (from $19.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found